U.S. Adds Nearly 200 Measles Cases Last Week

The case number in the U.S. for 2026 stands at 4,080; the country is on track to double 2025's total by the end of the year.

Key Highlights

  • - The US has reported 4,080 measles cases this year, the highest since 1991, with Pennsylvania being a major hotspot.
  • - 95% of cases involve unvaccinated individuals, highlighting the impact of vaccine hesitancy on outbreak severity.
  • - Pennsylvania alone has 1,136 confirmed cases, with a 19% hospitalization rate and five associated deaths, mostly in adults.
  • - The CDC is allocating $100 million to support outbreak response efforts across states.
  • - CDC officials reaffirm that the MMR vaccine is safe and effective in preventing measles.

The U.S. added another 194 measles cases last week, and the outbreak in Pennsylvania is showing no signs of slowing down. CIDRAP has the news.

The case number across the country stands at 4,080, which represents the highest number of measles cases in the U.S. since 1991. The nation is on track to double last year’s 2,289 cases before the end of the year. The CDC said there have been 42 outbreaks so far this year, and 96% of confirmed cases are outbreak-associated.

Of the cases this year, 17% are in children under the age of 5. Ten percent of case-patients have been hospitalized. However, the CDC only lists two deaths this year from measles, despite Pennsylvania alone identifying five measles-associated deaths. The vast majority of the cases (95%) are in people who are unvaccinated or whose vaccination status is unknown.

Pennsylvania’s outbreak shows no signs of slowing. The state has 1,136 confirmed cases; 99% of patients are unvaccinated, and the hospitalization rate is 19%. The five deaths might indicate that the outbreak is even larger than reported. 67% of the state’s cases have been in adults, which is unusual.

The CDC is sending $100 million to states to help with outbreak responses. CDC director Erica Schwartz reiterated that the MMR vaccine is “absolutely safe [and] absolutely effective.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt is Associate Editor for Healthcare Purchasing News.

Sign up for our eNewsletters
Get the latest news and updates